Bluefin celebrated one year since the launch of BLUE and the evolution into a multi-product ecosystem for onchain liquidity.Bluefin (@bluefinapp):2025 was the year Bluefin became a multi-product ecosystem, serving as a unified platform for onchain markets and liquidity. Today also marks one year since the launch of BLUE, our native protocol token, which stands as a core pillar of the Bluefin ecosystem.We are excited to https://t.co/vGr51RwubC ...

RT BSCN (@BSCNews)🚀 Meet the Sui Network tokens that have outperformed over the past 24-hours...- @overtake_world $TAKE [+33%]- @bluwhaleai $BLUEAI [+16%]- @DeepBookonSui $DEEP [+13%]- @navi_protocol $NAVX [+6%]- @WalrusProtocol $WAL [+6%]- @CetusProtocol $CETUS [+4%]- @SuiNetwork $SUI [+4%]- @bluefinapp $BLUE [+4%][Data: CMC] ...

RT BSCN (@BSCNews)🚀 Meet the Sui Network tokens that have outperformed over the past 24-hours...- @overtake_world $TAKE [+33%]- @bluwhaleai $BLUEAI [+16%]- @DeepBookonSui $DEEP [+13%]- @navi_protocol $NAVX [+6%]- @WalrusProtocol $WAL [+6%]- @CetusProtocol $CETUS [+4%]- @SuiNetwork $SUI [+4%]- @bluefinapp $BLUE [+4%][Data: CMC] ...

RT BSCN (@BSCNews)🚀 Meet the Sui Network tokens that have outperformed over the past 24-hours...- @overtake_world $TAKE [+33%]- @bluwhaleai $BLUEAI [+16%]- @DeepBookonSui $DEEP [+13%]- @navi_protocol $NAVX [+6%]- @WalrusProtocol $WAL [+6%]- @CetusProtocol $CETUS [+4%]- @SuiNetwork $SUI [+4%]- @bluefinapp $BLUE [+4%][Data: CMC] ...

Core Insights - Pangea Natural Foods Inc. has launched a portfolio of peptide products and a needle-less delivery system through its subsidiary Amino Innovations, focusing on health and wellness solutions [1][2] Peptide Market and Product Portfolio - Pangea completed the acquisition of Amino Innovations Corp. in Q2-2025, which specializes in non-injectable peptide therapies for various health indications [2] - The global peptide therapeutics market was valued at USD 117.26 billion in 2024 and is expected to grow to USD 260.25 billion by 2030, with a CAGR of 10.77% from 2025 to 2030 [3] - North America held a 60.21% share of the global peptide therapeutics market in 2024, with the U.S. leading due to strong biopharma investments and early regulatory approvals [3] - The pain segment is projected to see significant growth in the peptide therapeutics market from 2025 to 2030 [3] Digital Channels and Early Metrics - Amino Innovations launched an eCommerce platform in June 2025 for product education and direct-to-consumer sales [4] - Initial marketing efforts include influencer campaigns and user-generated content, with metrics being tracked for customer acquisition and lifetime value optimization [4] Novel Peptide Delivery Systems Pipeline - The company is developing patch and sublingual delivery systems to provide needle-free options, with a working patch prototype completed in August [5] - Third-party laboratories will be engaged in Q4-2025 to test the bioavailability and efficacy of these delivery systems [5] Manufacturing - All products are manufactured in the U.S. at a cGMP-certified facility, ensuring high standards of quality and consistency [6] - Selected products undergo third-party studies to measure stability and potency, reinforcing a commitment to data-driven formulation [7] New Website and Corporate Materials - Pangea has launched a new website and corporate materials to better reflect its mission in health and wellness following the acquisition of Amino Innovations [8] - The updated materials emphasize innovative, clean label products and a growing portfolio of nutritional supplements and personal care products [8] Company Overview - Pangea Natural Foods Inc. specializes in clean-label foods and wellness products, offering advanced needle-free peptide therapies through its subsidiary Amino Innovations [9]

#SmartSignal Daily Top 5 Gainers on #BitgetSpot📈 +116% $XTER @XterioGames📈 +39% $ONT @OntologyNetwork📈 +30 % $QTUM @qtum📈 +27% $ZKL @zkLink_Official📈 +22% $BLUE @bluefinappWhich coins are you trading today?https://t.co/r2DCtPMUL7 https://t.co/seO3zLCgAc ...